Recent Updates
Recently added Catalysts
NUS

NU SKIN ENTERPRISES REPORTS 42 PERCENT EPS GROWTH AND 15

Key Takeaway: NU SKIN ENTERPRISES REPORTS 42 PERCENT EPS GROWTH AND 15 PERCENT REVENUE GROWTH IN THE SECOND QUARTER PROVO, Utah - Aug. 4, 2021 - Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million and earnings per share (EPS) of $1.15 driven b

Full Press Release Details

NU SKIN ENTERPRISES REPORTS 42 PERCENT EPS GROWTH AND
15 PERCENT REVENUE GROWTH IN THE SECOND QUARTER
PROVO, Utah - Aug. 4, 2021 - Nu Skin Enterprises, Inc. (NYSE: NUS) today announced second-quarter 2021 revenue of $704.1 million and earnings per share (EPS) of
$1.15 driven by an increase in operating margin of 260 basis points.
Q2 2021 vs. Prior-year Quarter
Revenue: $704.1 million; +15% +6% fx impact or $36.9 million
Earnings Per Share (EPS): $1.15; +42%
Sales Leaders: 64,228; +15%
Customers: 1,467,617; (2%)
"Our growth and success this quarter and over the past year reflect our strategy of delivering world-class beauty and wellness products, being customer obsessed,
and digitally enabling our business," said Ritch Wood, chief executive officer. "Our performance was led by continued growth in our beauty device systems and further adoption of social commerce. In addition, we significantly improved profitability
during the quarter, which led to strong earnings per share growth. We have a solid foundation in place, and I am fully confident in Ryan and our leadership team to build on the momentum and take Nu Skin to the next level."
Ryan Napierski, president and CEO-elect, added, "We continue to advance our vision of becoming the world's leading beauty and wellness company, powered by our
dynamic affiliate opportunity platform. During the quarter, we strengthened our position as the market leader in beauty device systems as our latest device system, ageLOC Boost, generated momentum with a strong launch in EMEA. Additionally, we are
pleased with the rollout of Nutricentials Bioadaptives, which is targeted at a millennial/Gen Z consumer. In the back half of the year, we will be begin rolling out Beauty Focus Collagen+, which leverages our unique strength in both beauty and
wellness, and ageLOC Meta, our next significant Pharmanex product introduction.
"We are pleased with 15 percent growth in sales leaders, while customers declined slightly due to a significant surge in the prior year. To better support our
affiliates with customer acquisition, we will be rolling out additional digital tools over the next several quarters such as personalized social commerce shops in Mainland China. This represents a significant step forward in deploying our digital
tools in the world's largest social commerce market."
Q2 2021 Year-over-year Operating Results
Revenue: $704.1 million compared to $612.4 million +6% fx impact
Gross Margin: 75.6% compared to 74.8% Nu Skin business was 78.3% compared to 77.6%
Selling Expenses: 39.5% compared to 40.6% Nu Skin business was 42.4% compared to 43.3%
G&A Expenses: 24.0% compared to 24.7%
Operating Margin: 12.1% compared to 9.5%
Other Income / (Expense): ($4.0) million compared to $1.6 million
Income Tax Rate: 27.1% compared to 29.8% Benefited by geographic mix
EPS: $1.15 compared to $0.81
Dividend Payments: $19.0 million
Stock Repurchases: $10.0 million $265.4 million remaining in authorization
Q3 and Full-year 2021 Outlook
Q3 2021 Revenue: $700 to $730 million; 0 to 4% Approximately +2 to 3% fx impact
Q3 2021 EPS: $1.10 to $1.20; +2 to 11%
2021 Revenue: $2.81 to $2.87 billion; +9 to 11% Approximately +3 to 4% fx impact
2021 EPS: $ 4.30 to $4.50; +18 to 24%
Mark Lawrence, chief financial officer, added, "We reported 42 percent EPS growth driven by strong
improvements in both gross margin and operating margin as a result of continued expense control and supply chain efficiency. We are raising our EPS guidance for the year as we continue to focus on generating enhanced value for our shareholders."
About Nu Skin Enterprises, Inc.
Founded more than 35 years ago, Nu Skin Enterprises, Inc. (NSE) empowers innovative companies with sustainable solutions, opportunities, technologies and
life-improving values. The company currently focuses its efforts around innovative consumer products, product manufacturing and controlled environment agriculture technology. The NSE family of companies includes Nu Skin, which develops and
distributes a comprehensive line of premium-quality beauty and wellness solutions through a global network of sales leaders in Asia, the Americas, Europe, Africa and the Pacific; and Rhyz, our strategic investment arm that includes a collection of
sustainable manufacturing and technology innovation companies. Nu Skin Enterprises is traded on the New York Stock Exchange under the symbol "NUS." More information is available at nuskinenterprises.com.
Important Information Regarding
Forward-Looking Statements: This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the
Securities Exchange Act of 1934, as amended, that represent the company's current expectations and beliefs. All statements other than statements of historical fact are "forward-looking statements" for purposes of federal and state securities laws
and include, but are not limited to, statements of management's expectations regarding the company's performance, growth, shareholder value, vision, product pipeline and product introductions, digital tools, customers and sales leaders, affiliates,
strategies and initiatives; projections regarding revenue, earnings per share, foreign currency fluctuations and other financial items; statements of belief; and statements of assumptions underlying any of the foregoing. In some cases, you can
identify these statements by forward-looking words such as "believe," "expect," "anticipate," "project," "outlook," "guidance," "plan," "forecast," "expand," "will," "would," "could," "may," "might," the negative of these words and other similar
The forward-looking statements and related assumptions involve risks and uncertainties that could cause actual results and outcomes to differ
materially from any forward-looking statements or views expressed herein. These risks and uncertainties include, but are not limited to, the following:
The company's financial performance and the forward-looking statements contained herein are further qualified by a detailed discussion of
associated risks set forth in the documents filed by the company with the Securities and Exchange Commission. The forward-looking statements set forth the company's beliefs as of the date that such information was first provided, and the company
assumes no duty to update the forward-looking statements contained in this release to reflect any change except as required by law.
Non-GAAP Financial Measures: Constant-currency revenue change is a non-GAAP financial measure that removes the impact of fluctuations in foreign-currency exchange rates, thereby facilitating period-to-period comparisons of the
company's performance. It is calculated by translating the current period's revenue at the same average exchange rates in effect during the applicable prior-year period and then comparing that amount to the prior-year period's revenue. The company
believes that constant-currency revenue change is useful to investors, lenders and analysts because such information enables them to gauge the impact of foreign-currency fluctuations on the company's revenue from period to period.
The following table sets forth revenue for the three-month periods ended June 30, 2021 and 2020 for each of our reportable segments (U.S. dollars in
Three Months Ended June 30, Constant- Currency
2021 2020 Change Change
Nu Skin
Mainland China $ 154,182 $ 146,332 5 % (4 )%
Americas/Pacific 151,730 127,919 19 % 14 %
South Korea 88,604 76,915 15 % 6 %
EMEA 83,115 50,776 64 % 49 %
Southeast Asia 70,751 66,829 6 % 2 %
Japan 68,020 68,291 - 1 %
Hong Kong/Taiwan 38,529 37,161 4 % -
Nu Skin other 755 (85 ) 988 % 988 %
Total Nu Skin 655,686 574,138 14 % 8 %
Rhyz Investments
Manufacturing 48,140 37,918 27 % 27 %
Grow Tech 191 310 (38 )% (38 )%
Rhyz other 38 -
Total Rhyz Investments 48,369 38,228 27 % 27 %
Total $ 704,055 $ 612,366 15 % 9 %
The following table sets forth revenue for the six-month periods ended June 30, 2021 and 2020 for each of our reportable segments (U.S. dollars in thousands):
Six Months Ended June 30, Constant- Currency
2021 2020 Change Change
Nu Skin
Mainland China $ 303,775 $ 284,028 7 % (2 )%
Americas/Pacific 301,195 202,492 49 % 45 %
South Korea 169,735 152,634 11 % 3 %
EMEA 159,295 86,179 85 % 69 %
Southeast Asia 138,336 136,415 1 % (2 )%
Japan 137,884 129,591 6 % 6 %
Hong Kong/Taiwan 74,874 72,988 3 % (1 )%
Nu Skin other 1,460 688 112 % 112 %
Total Nu Skin 1,286,554 1,065,015 21 % 15 %
Rhyz Investments
Manufacturing 94,125 65,065 45 % 45 %
Grow Tech 364 314 16 % 16 %
Rhyz other 38 -
Total Rhyz Investments 94,527 65,379 45 % 45 %
Total $ 1,381,081 $ 1,130,394 22 % 16 %
The company's Customers and Sales Leaders statistics by segment as of June 30, 2021 and 2020 are presented in the following table:
As of June 30, 2021 As of June 30, 2020 % Increase (Decrease)
Customers Sales Leaders Customers Sales Leaders Customers Sales Leaders
Mainland China 328,526 18,647 321,946 17,104 2 % 9 %
Americas/Pacific 397,685 13,078 424,236 10,787 (6 )% 21 %
South Korea 153,287 7,935 159,926 6,881 (4 )% 15 %
EMEA 261,857 7,900 247,057 5,120 6 % 54 %
Southeast Asia 135,610 7,141 155,822 6,790 (13 )% 5 %
Japan 125,791 6,053 125,332 6,011 - 1 %
Hong Kong/Taiwan 64,861 3,474 65,581 3,343 (1 )% 4 %
Total 1,467,617 64,228 1,499,900 56,036 (2 )% 15 %
"Customers" are persons who purchased products directly from the company during the previous three months. Our Customer numbers do not include consumers who purchase products directly from members of our sales force.
"Sales Leaders" are independent distributors, and sales employees and independent marketers in China, who achieve certain qualification requirements.
NU SKIN ENTERPRISES, INC.
Consolidated Statements of Income (Unaudited)
(U.S. dollars in thousands, except per share amounts)
Three Months Ended June 30, Six Months Ended June 30,
2021 2020 2021 2020
Revenue $ 704,055 $ 612,366 $ 1,381,081 $ 1,130,394
Cost of sales 171,975 154,110 342,541 279,903
Gross profit 532,080 458,256 1,038,540 850,491
Operating expenses:
Selling expenses 277,893 248,628 551,639 454,670
General and administrative expenses 168,811 151,554 338,612 301,182
Total operating expenses 446,704 400,182 890,251 755,852
Operating income 85,376 58,074 148,289 94,639
Other income (expense), net (4,012 ) 1,581 (2,430 ) (4,593 )
Income before provision for income taxes 81,364 59,655 145,859 90,046
Provision for income taxes 22,026 17,804 39,091 28,465
Net income $ 59,338 $ 41,851 $ 106,768 $ 61,581
Net income per share:
Basic $ 1.18 $ 0.81 $ 2.12 $ 1.15
Diluted $ 1.15 $ 0.81 $ 2.06 $ 1.15
Weighted-average common shares outstanding (000s):
Basic 50,115 51,872 50,409 53,466
Diluted 51,557 51,925 51,850 53,502
NU SKIN ENTERPRISES, INC.
Consolidated Balance Sheets (Unaudited)
(U.S. dollars in thousands)
June 30, 2021 December 31, 2020
ASSETS
Current assets:
Cash and cash equivalents $ 354,759 $ 402,683
Current investments 24,499 21,216
Accounts receivable, net 64,701 63,370
Inventories, net 390,977 314,366
Prepaid expenses and other 126,586 101,563
Total current assets 961,522 903,198
Property and equipment, net 474,167 468,181
Operating lease right-of-use assets 136,738 155,104
Goodwill 215,582 202,979
Other intangible assets, net 98,955 89,532
Other assets 163,016 138,082
Total assets $ 2,049,980 $ 1,957,076
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
Accounts payable $ 60,632 $ 66,174
Accrued expenses 403,165 446,682
Current portion of long-term debt 152,500 30,000
Total current liabilities 616,297 542,856
Operating lease liabilities 100,826 112,275
Long-term debt 288,343 305,393
Other liabilities 126,688 102,281
Total liabilities 1,132,154 1,062,805
Commitments and contingencies
Stockholders' equity:
Class A common stock - 500 million shares authorized, $0.001 par value, 90.6 million shares issued 91 91
Additional paid-in capital 586,976 579,801
Treasury stock, at cost - 40.4 million and 39.7 million shares (1,509,867 ) (1,461,593 )
Accumulated other comprehensive loss (68,553 ) (64,768 )
Retained earnings 1,909,179 1,840,740
Total stockholders' equity 917,826 894,271
Total liabilities and stockholders' equity $ 2,049,980 $ 1,957,076
Media: media@nuskin.com, (801) 345-6397
Investors: investorrelations@nuskin.com, (801) 345-3577
Last updated: Aug 4, 2021